Another night, another ORANGE MAN BAD article from the New York Times, this time by Ken Vogel who is actually a good reporter, so what the f-ck was he even thinking. Anyhow, the article suggests that Trump is recommending hydroxychloroquine because Trump holds stock in the drug maker Sanofi. How much stock? That’s left out of the article, which is a sure sign for a Cernocheck.
According to Trump’s 2019 financial disclosure, he owns between $1,000 and $15,000 in a Dodge & Cox fund.
According to Dox & Cox’s prospectus, their fund’s assets are 2.9% Sanofi.
Assume Trump is at the high end of the disclosure range. Round it up to $15,000.
Trump owns 2.9% worth of $15,000.
It’s also worth noting that hydroxychloroquine is off-patent, so even if Sanofi is mass producing it, this isn’t going to push the stock up.
And my math assumes Trump is at $15,000 and not $1,000.
In which case Trump would own 2.9% of $1,000 – or $29 total.
P.S. Watch Hoaxed Movie!